Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 21, 2023

BUY
$45.44 - $74.26 $112,282 - $183,496
2,471 Added 11.42%
24,110 $1.58 Million
Q4 2022

Feb 16, 2023

BUY
$41.39 - $81.0 $895,638 - $1.75 Million
21,639 New
21,639 $973,000
Q2 2022

Aug 11, 2022

BUY
$87.2 - $114.05 $6,452 - $8,439
74 New
74 $8,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Ghp Investment Advisors, Inc. Portfolio

Follow Ghp Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghp Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ghp Investment Advisors, Inc. with notifications on news.